Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$909.04 7.78 (0.86%) as of 4:30 Thu 6/27


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 869.57(B)
Last Volume: 1,947,382 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,815,444 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 51 93
End Date 2024-03-30 2023-12-28 2023-06-29 2022-06-29

   
Records found: 1436
  Page 38 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fry Stephen F SVP, HR & Diversity   •       –      –    2018-01-29 4 A $87.60 $870,481 D/D 9,937 90,760     -
   Ricks David A President & CEO   •       •      –    2018-01-29 4 A $87.60 $1,086,853 D/D 12,407 119,483     -
   Norton Johna Senior VP, Global Quality   •       –      –    2018-01-29 4 A $87.60 $140,072 D/D 1,599 16,092     -
   Oneill Myles SVP & Pres., Mfg. Operations   •       –      –    2018-01-29 4 A $87.60 $481,012 D/D 5,491 32,053     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2018-01-29 4 A $87.60 $169,331 D/D 1,933 5,030     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2018-01-29 4 A $87.60 $1,109,191 D/D 12,662 130,794     -
   Alvarez Ralph Director   –       •      –    2018-01-16 4/A A $85.29 $10,917 D/D 128 39,630     -
   Luciano Juan R Director   –       •      –    2018-01-16 4/A A $85.29 $9,638 D/D 113 5,426     -
   Fyrwald J Erik Director   –       •      –    2018-01-16 4/A A $85.29 $5,459 D/D 64 58,159     -
   Luciano Juan R Director   –       •      –    2018-01-15 4 A $85.29 $9,638 D/D 113 5,426     -
   Fyrwald J Erik Director   –       •      –    2018-01-15 4 A $85.29 $5,459 D/D 64 58,159     -
   Alvarez Ralph Director   –       •      –    2018-01-15 4 A $85.29 $10,917 D/D 128 39,630     -
   Luciano Juan R Director   –       •      –    2017-12-18 4 A $86.08 $9,641 D/D 112 5,313     -
   Alvarez Ralph Director   –       •      –    2017-12-18 4 A $86.08 $10,932 D/D 127 39,502     -
   Lilly Endowment Inc 10% Owner   –       –       •   2017-12-13 4 S $88.17 $17,639,176 D/D (200,000) 123,075,804     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2017-12-11 4 AS $86.46 $1,080,750 D/D (12,500) 124,522     -
   Zulueta Alfonso G SVP & President, Lilly Intl   •       –      –    2017-12-04 4 AS $86.00 $303,752 D/D (3,532) 40,048     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2017-12-04 4 AS $86.18 $3,152,895 D/D (36,585) 54,885     -
   Ricks David A President & CEO   •       •      –    2017-12-03 4 D $85.32 $221,917 D/D (2,601) 107,458     -
   Ricks David A President & CEO   •       •      –    2017-12-03 4 OE $0.00 $0 D/D 5,496 110,059     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2017-12-03 4 D $85.32 $91,292 D/D (1,070) 3,097     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2017-12-03 4 OE $0.00 $0 D/D 3,281 4,167     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2017-12-03 4 D $85.32 $304,336 D/D (3,567) 82,934     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2017-12-03 4 OE $0.00 $0 D/D 7,557 86,501     -
   Hoover R David Director   –       •      –    2017-11-20 4 A $83.18 $160,038 D/D 1,924 36,284     -
  1436 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 38 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us